Tapentadol Synthesis via Hydrosilane Deoxygenation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for preparing Tapentadol require expensive reagents and complicated procedures, particularly for accessing the S,S-diastereomer of compound III, which results in lower yields and increased costs.
Innovation Solution
A process involving deoxygenation of compound IIIa using a hydrosilane reagent and an acid to produce compound IIa, followed by separation of diastereomers and demethylation to obtain Tapentadol, avoiding the need for expensive hydrogenation reagents and complex starting materials.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If hydrogenation with transition metal catalyst is used to prepare compound IIa, then the reaction proceeds efficiently, but expensive reagents and equipment are required
Solution Approach 1:
The patent replaces expensive transition metal catalysts (Palladium on carbon) with a cheaper, disposable acid catalyst system using trifluoroacetic acid and silane reagents. This substitution eliminates the need for expensive metal catalysts while maintaining reaction efficiency, directly resolving the contradiction between productivity and manufacturing cost.
Solution Approach 2:
The patent changes the reaction parameters by switching from hydrogenation conditions (requiring H2 gas and metal catalyst) to a chemically different deoxygenation pathway using silane and acid. This parameter change allows the reaction to proceed efficiently without expensive reagents, resolving the cost-efficiency contradiction.
2Manufacturing precision
If the S,S-diastereomer (compound IIIb) is used as starting material, then the desired diastereomer IIa can be obtained, but the preparation procedure is more complicated and yield is lower
Solution Approach 1:
Instead of using the conventional S,S-diastereomer (IIIb) as starting material which requires complicated preparation procedures, the patent inverts the approach by using the readily available R,R-diastereomer (IIIa) as starting material. The deoxygenation reaction selectively produces the desired R,R-diastereomer (IIa) with high diastereomeric purity, simplifying the overall procedure while maintaining product quality.
Solution Approach 2:
The patent extracts or removes the problematic step of preparing the S,S-diastereomer by directly using the commercially available R,R-diastereomer (IIIa) instead. This eliminates the complicated preparation route and low-yield steps associated with accessing the S,S-diastereomer, while still achieving the desired product through the deoxygenation reaction.
3Manufacturing precision
If multiple fractional crystallization steps are performed to separate diastereomers, then desired diastereomeric purity is achieved, but the process time and complexity increase
Solution Approach 1:
The patent performs preliminary action by selecting the appropriate starting material diastereomer (R,R-IIIa) that will directly yield the desired product diastereomer (R,R-IIa) through deoxygenation. This preliminary selection eliminates the need for subsequent time-consuming separation steps, as the reaction itself provides high diastereomeric purity in a single step.
Solution Approach 2:
The patent extracts or eliminates the need for multiple fractional crystallization steps by using a reaction pathway that inherently produces high diastereomeric purity. The deoxygenation of R,R-IIIa directly yields R,R-IIa with sufficient purity, removing the time-consuming separation process entirely or reducing it to a single step.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This process provides a more cost-effective and efficient synthesis of Tapentadol by utilizing readily available reagents and simplifying the production steps, improving yield and reducing the complexity of accessing the desired diastereomer.
Implementation Method 1
performing deoxygenation of compound of formula IIIa or a salt thereof in the presence of a hydrosilane reagent and an acid to provide compound of formula IIa
Data Source
AI summary
The present invention relates to a novel process for the preparation of Tapentadol and intermediate compound 2R, 3R)-3-(-methoxyphenyl)-N,N,2-trimethylpentanamine (compound of formula IIa).